TrueWealth Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.94M Buy
123,684
+13,411
+12% +$320K 0.66% 25
2026
Q1
$2.63M Buy
110,273
+18,047
+20% +$435K 0.66% 27
2025
Q4
$2.23M Buy
92,226
+7,947
+9% +$192K 0.58% 33
2025
Q3
$2.04M Buy
84,279
+2,495
+3% +$60K 0.55% 38
2025
Q2
$1.96M Buy
81,784
+1,724
+2% +$40.9K 0.58% 34
2025
Q1
$1.9M Buy
80,060
+39,501
+97% +$933K 0.62% 37
2024
Q4
$951K Buy
40,559
+7,828
+24% +$186K 0.32% 67
2024
Q3
$788K Buy
32,731
+18,920
+137% +$451K 0.26% 75
2024
Q2
$322K Buy
13,811
+1,130
+9% +$26.3K 0.12% 138
2024
Q1
$298K Buy
12,681
+183
+1% +$4.3K 0.12% 147
2023
Q4
$295K Sell
12,498
-323
-3% -$7.38K 0.11% 145
2023
Q3
$290K Sell
12,821
-442
-3% -$10.1K 0.12% 136
2023
Q2
$306K Buy
13,263
+539
+4% +$12.5K 0.13% 128
2023
Q1
$298K Buy
12,724
+3,285
+35% +$76.3K 0.13% 135
2022
Q4
$217K Buy
+9,439
New +$215K 0.1% 168

Other funds holding IBD

TrueWealth Advisors's IBD Position: Q2 2026 in Review

TrueWealth Advisors increased its Inspire Corporate Bond ETF (IBD) stake by 12% in Q2 2026, buying an estimated $320K and bringing the position to 123,684 shares worth $2.94M. The position accounts for 0.66% of the portfolio, ranked #25.

TrueWealth Advisors first reported a position in IBD in Q4 2022 and has held it in 15 quarters since. 18 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • TrueWealth Advisors held 123,684 shares of Inspire Corporate Bond ETF worth $2.94M as of Q2 2026.
  • TrueWealth Advisors bought 13,411 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $320K.
  • Inspire Corporate Bond ETF made up 0.66% of TrueWealth Advisors's portfolio in Q2 2026, its #25 holding.
  • TrueWealth Advisors first reported a position in Inspire Corporate Bond ETF in Q4 2022 and has held it in 15 quarters since.
  • 18 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on TrueWealth Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.